Sennosides 7.5mg tablets

Country: Велика Британија

Језик: Енглески

Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активни састојак:

Senna fruit

Доступно од:

Alissa Healthcare Research Ltd

АТЦ код:

A06AB06

INN (Међународно име):

Senna fruit

Дозирање:

7.5mg

Фармацеутски облик:

Oral tablet

Пут администрације:

Oral

Класа:

No Controlled Drug Status

Тип рецептора:

Valid as a prescribable product

Резиме производа:

BNF: 01060200

Информативни летак

PATIENT INFORMATION LEAFLET
SENNOSIDES 7.5 MG TABLETS
READ
ALL
OF
THIS
LEAFLET
CAREFULLY
BEFORE
YOU
START
TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
Always take this medicine exactly as described in this
leaflet or as your pharmacist has told you.
•
Keep this leaflet. You may need to read it again
•
Ask your pharmacist if you need more information or
advice
•
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4
•
You must talk to a doctor if you do not feel better or if
you feel worse
WHAT IS IN THIS LEAFLET:
1. What Sennosides 7.5 mg tablets are and what they
are used for
2. What you need to know before you take Sennosides
7.5 mg tablets
3. How to take Sennosides 7.5 mg tablets
4. Possible side effects
5. How to store Sennosides 7.5 mg tablets
6. Contents of the pack and other information
1. WHAT SENNOSIDES 7.5 MG TABLETS ARE
AND WHAT THEY ARE USED FOR
Sennosides 7.5 mg tablets are used for the short term
relief of occasional constipation. This medicine does not
help with weight loss.
2. WHAT YOU NEED TO KNOW BEFORE YOU
TAKE SENNOSIDES 7.5 MG TABLETS
DO NOT TAKE IF YOU:
•
are allergic to any of the ingredients (for a full list of
ingredients, see section 6)
•
have blockage or narrowing of the gastro-intestinal
tract
or
bowel
(ileus,
intestinal
obstruction
or
stenosis)
•
have paralysis or a lack of muscle tone in the bowel
(atony)
•
have appendicitis, inflammatory bowel disease such
as Crohn’s disease or ulcerative colitis
•
have severe dehydration
•
have
persistent
or
undiagnosed
abdominal
complaints e.g. pain, nausea, or vomiting
•
have faecal impaction or rectal bleeding for which
you don’t know the cause, or blood in your stools
•
have already taken a laxative and are still constipated
•
have had a sudden change in bowel habit that has
lasted for more than 2 weeks
•
have kidney or heart failure
5. HOW TO STORE SENNOSIDES
7.5 MG TABLETS
KEEP
THIS
MEDICINE
OUT

Карактеристике производа

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Sennosides 7.5mg tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains
Sennosides (as calcium salts) equivalent to 7.5mg of Hydroxyanthracene
glycosides,
calculated as Sennoside B.
Each tablet contains 15mg of lactose monohydrate (See Section 4.4
Special warnings
and precautions for use)
For full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Tablets
Brown coloured, speckled, circular, uncoated tablets debossed ‘BP’
on one side and
‘1’ on other side.
Approximate size of the tablet is 9mm (diameter)
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the short term relief of occasional constipation
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral use only
The correct individual dose is the smallest required to produce a
comfortable soft-
formed motion.
ADULTS, ELDERLY AND CHILDREN OVER 12 YEARS OLD: Two tablets taken at
bedtime
(Tablets should be taken as a single dose) under guidance of a medical
professional.
CHILDREN OVER 6-12 YEARS: One tablet to be taken at bed time.
CHILDREN UNDER 6 YEARS: Not recommended.
The dose should be decreased as the bowel habit becomes regular.
Duration of use
Usually it is sufficient to take this medicinal product up to two to
three times a week.
Use for more than 1 – 2 weeks requires medical supervision.
If there is no bowel movement after three days, a doctor should be
consulted.
If laxatives are needed every day, or abdominal pain persists, a
doctor should be
consulted.
If the symptoms worsen, or persist during the use of the medicinal
product, a doctor
or a pharmacist should be consulted.
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients.
Not to be used at the same time as other laxative agents.
Cases of intestinal obstructions and stenosis, atony, appendicitis,
inflammatory colon
diseases (e.g Crohn’s disease, ulcerative colits), abdominal pain of
unknown origin,
severe dehydration state with water and electrolyte depletion.